DISAB

Connect with us

National

BioVaxys Files Patent Application for Novel COVID-19 Diagnostic for T-Cell Immunity – MENAFN.COM

BioVaxys Files Patent Application for Novel COVID-19 Diagnostic for T-Cell ImmunityVancouver, British Columbia–(Newsfile Corp. – November 2, 2020) – BioVaxys Technology…

Published

on

post featured image

(MENAFN – Newsfile Corp) BioVaxys Files Patent Application for Novel COVID-19 Diagnostic for T-Cell Immunity
Vancouver, British Columbia–(Newsfile Corp. – November 2, 2020) – BioVaxys Technology Corp. (CSE: BIOV) (“BioVaxys” or “the Company”), a world leader in haptenized protein vaccine research and development, announced today that it has filed a Provisional Patent Application with the U.S. Patent and Trademark Office entitled METHOD AND KIT FOR DETECTION OF CELL MEDIATED IMMUNE RESPONSE related…

Click here to view the original article.

Safety Mate